Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness.
about
Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, ChinaInvolvement of Kallikrein-Related Peptidases in Normal and Pathologic ProcessesEmerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignanciesHuman kallikrein 8 expression in salivary gland tumors.Correlation between KLK6 expression and the clinicopathological features of glioma.High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis.Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy.Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung.Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.Functional characterization of the human-specific (type II) form of kallikrein 8, a gene involved in learning and memory.Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.
P2860
Q24645582-3FFEB30F-4EF8-4DC8-8E10-D698B88D2A63Q26771266-48070A80-C702-49EF-B38C-6429FF1693F3Q27007065-F5375716-2A83-4B1B-A905-0F91EECE3869Q33594956-63A5621D-B377-4270-8B1E-F9C7DAE09044Q34226804-0576E91B-4181-4581-8C8F-2A606B31AA8BQ35893466-55D00026-DB26-4340-8321-468D8E28B4C9Q36517193-498D5117-2513-400E-9EC1-EF2731303673Q37690308-8B317627-FAC4-4DE7-B152-80C87602628CQ37714914-01893945-E444-4DC0-8E1A-EFCAA4C20CD5Q39961334-547A7F18-A782-4CCA-A689-F5C1222A6CAAQ40811309-21F0CFDF-2BBF-4DC9-BDD8-165A9FD9A194Q41441753-43A37E79-E171-46E8-AE22-30BB1FA76FF2Q46174244-10BABA50-FA2B-4D8A-B374-0F71DA51C2F1Q46588877-7D3E837B-4AFB-4E3E-A53E-25C8E84E8162Q54976872-B16BB07E-464B-4730-A25B-31F3483B9BFAQ55036871-25DCC16D-50C3-4A2A-B489-A21A92F358BD
P2860
Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@ast
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@en
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@nl
type
label
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@ast
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@en
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@nl
prefLabel
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@ast
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@en
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@nl
P2093
P1433
P1476
Human kallikrein 8 protease co ...... ssing tumor cell invasiveness.
@en
P2093
Cheng-Chung Chou
Cheng-Wen Wu
Chia-Li Yu
Chun-Houh Chen
Han-Ming Wu
Konan Peck
Pan-Chyr Yang
Ruey-Hwang Chou
Wun-Shaing Wayne Chang
Yuh-Pyng Sher
P304
11763-11770
P356
10.1158/0008-5472.CAN-06-3165
P407
P577
2006-12-01T00:00:00Z